Ecological and Evolutionary Alterations in Graves’ Disease Gut Microbiome Reveal Specific Diagnostic Biomarkers

Qiyun Zhu,Qiangchuan Hou,Shi Huang,Qianying Ou,Yoshiki Vázquez-Baeza,Dongxue Huo,Chaoping Cen,Victor Cantu,Mehrbod Estaki,Haibo Chang,Pedro Belda-Ferre,Ho-Cheol Kim,Kaining Chen,Rob Knight,Jiachao Zhang

DOI: https://doi.org/10.21203/rs.3.rs-113330/v1

2020-11-25

Abstract:Abstract Background : Graves’ Disease (GD) is the most common organ-specific autoimmune disease and has been linked in small pilot studies to taxonomic markers within the gut microbiome. However, the small sample size and limited resolution of the 16S rRNA amplicon sequencing technology limited the universality and significance of these studies. Larger cohorts and integration of different levels of analysis from high-resolution shotgun metagenomics data were therefore needed to explore the GD patients’ alteration in gut microbial taxonomy, genes, pathways and functions, metabolites, and mutational spectra, to establish robust microbial biomarkers at these levels for GD diagnosis. Results : Here, we studied 162 gut microbiomes of mild and severe Graves’ disease (GD) patients and healthy controls. Shotgun metagenomic sequencing and inferred metabolomics were applied to describe the intestinal microbial characteristics and microbial mutations of GD patients. Then, combined biomarkers were identified from machine learning. Finally, we performed a meta-analysis to confirm the specificity of these biomarkers across different metabolic and autoimmune diseases. Taxonomic and functional analyses based on metagenome-assembled genomes (MAGs) and MAG-annotated genes, together with predicted metabolic functions and metabolite profiles, revealed a bipartite co-occurrence network of MAGs, genes and clinical indexes separating healthy from GD subjects. A supervised classification model identified a combination of biomarkers including microbial species, MAGs, genes and SNPs, with predictive power superior to models from any single biomarker type (AUC=0.98). Global, cross-disease meta-analysis of gut microbiomes revealed high specificity of these GD biomarkers, notably discriminating against Parkinson’s Disease, and suggesting that non-invasive stool-based diagnostics will be useful for these diseases. Conclusions : This work extended our understanding of the microbial ecology and evolution of GD pathogenesis, and developed a useful predictive model for GD diagnosis based on intestinal microbial biomarkers.